[Hub]/) : Traits : Impedance of arm (right) :

chr6:87,167,376-88,880,701

Best TWAS P=1.25e-09 · Best GWAS P=5.61e-09 conditioned to 0.541

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 CommonMind Brain Pre-frontal Cortex ZNF292 0.04 0.05 lasso 12 0.03 4.1e-05 5.0 -5.2 1.8e-07 0.88 0.26 0.73 FALSE
2 GTEx Artery Aorta RP11-393I2.4 0.10 0.03 lasso 5 0.02 2.4e-02 4.7 -5.3 1.4e-07 0.75 0.10 0.82 FALSE
3 GTEx Cells EBV-transformed lymphocytes C6orf163 0.18 0.14 lasso 4 0.15 1.5e-05 5.7 5.6 2.3e-08 -0.79 0.05 0.92 FALSE
4 GTEx Cells Transformed fibroblasts SMIM8 0.18 0.14 lasso 5 0.12 1.4e-09 5.7 -5.7 1.2e-08 0.80 0.03 0.97 FALSE
5 GTEx Cells Transformed fibroblasts C6orf163 0.16 0.14 lasso 3 0.18 2.7e-13 5.7 5.7 1.5e-08 -0.72 0.05 0.95 FALSE
6 GTEx Nerve Tibial ZNF292 0.09 0.07 enet 16 0.10 1.5e-07 -5.6 -5.7 1.4e-08 0.92 0.13 0.87 FALSE
7 GTEx Nerve Tibial RP11-393I2.4 0.08 0.09 enet 18 0.09 6.8e-07 4.9 -5.7 9.3e-09 0.87 0.05 0.95 FALSE
8 GTEx Stomach C6orf163 0.10 0.06 lasso 1 0.05 2.3e-03 5.6 5.6 1.8e-08 -0.79 0.04 0.87 FALSE
9 METSIM Adipose C6orf164 0.05 0.06 lasso 8 0.06 9.3e-10 5.7 5.5 3.6e-08 -0.81 0.05 0.95 FALSE
10 ROSMAP Brain Pre-frontal Cortex SLC35A1 0.30 0.48 enet 25 0.50 5.7e-73 -5.5 -5.4 6.1e-08 0.74 0.09 0.91 FALSE
11 The Cancer Genome Atlas Cervical Squamous Cell Carcinoma C6orf164 0.07 0.06 blup 95 0.05 2.0e-03 -5.8 5.7 9.1e-09 -0.95 0.03 0.95 FALSE
12 The Cancer Genome Atlas Colon Adenocarcinoma C6orf164 0.05 0.02 enet 8 0.02 1.9e-02 -5.6 5.4 7.2e-08 -0.99 0.03 0.69 FALSE
13 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma C6orf164 0.06 0.08 blup 94 0.08 8.3e-09 -5.6 5.4 6.1e-08 -0.93 0.02 0.98 FALSE
14 The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma C6orf164 0.11 0.14 enet 8 0.12 1.6e-07 -5.7 5.9 3.3e-09 -0.99 0.02 0.98 FALSE
15 The Cancer Genome Atlas Brain Lower Grade Glioma C6orf164 0.04 0.02 blup 95 0.04 5.4e-05 5.7 6.1 1.3e-09 -0.92 0.02 0.98 TRUE
16 The Cancer Genome Atlas Lung Adenocarcinoma C6orf164 0.09 0.12 blup 95 0.11 4.1e-13 -5.7 5.5 4.4e-08 -0.96 0.02 0.98 FALSE
17 The Cancer Genome Atlas Lung Squamous Cell Carcinoma C6orf164 0.06 0.06 lasso 4 0.07 4.6e-08 -5.8 5.4 8.5e-08 -0.97 0.02 0.98 FALSE
18 The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma C6orf163 0.06 0.02 blup 66 0.02 1.1e-02 5.6 5.8 7.4e-09 -0.84 0.02 0.85 FALSE
19 The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma C6orf164 0.12 0.12 blup 95 0.14 7.4e-10 -5.1 5.5 3.3e-08 -0.92 0.03 0.97 FALSE
20 The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma SLC35A1 0.04 0.03 lasso 5 0.02 1.3e-02 -5.5 5.4 7.1e-08 -0.74 0.01 0.90 FALSE
21 The Cancer Genome Atlas Pancreatic Adenocarcinoma C6orf164 0.07 0.11 enet 8 0.10 8.4e-05 -5.7 5.5 4.2e-08 -0.99 0.03 0.94 FALSE
22 The Cancer Genome Atlas Stomach Adenocarcinoma C6orf164 0.17 0.13 lasso 4 0.10 6.2e-08 -5.7 5.6 1.9e-08 -0.98 0.02 0.98 FALSE
23 The Cancer Genome Atlas Thyroid Carcinoma C6orf164 0.18 0.24 lasso 4 0.25 1.4e-24 -5.7 5.7 9.3e-09 -0.99 0.02 0.98 FALSE
24 The Cancer Genome Atlas Thyroid Carcinoma SLC35A1 0.08 0.07 enet 17 0.07 5.0e-07 -5.3 -5.3 1.5e-07 0.74 0.01 0.99 FALSE